Ignite Creation Date:
2024-10-26 @ 3:35 PM
Last Modification Date:
2024-10-26 @ 3:35 PM
Study NCT ID:
NCT06513195
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-07-08
Brief Title:
EUS-guided Response Assessment to NSBB
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Endoscopic Ultrasound Guided Response Assessment to Non-selective Beta-blockers in the Treatment of Clinically Significant Portal Hypertension
Status:
RECRUITING
Status Verified Date:
2023-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The goal of this clinical trial is to learn if endoscopic ultrasound EUS-guided portal pressure measurement can determine the treatment response to non-selective beta-blockers NSBB in patients with cirrhosis and clinically significant portal hypertension CSPH Participants will undergo EUS-guided portal pressure measurement before start of Carvedilol en after three months of treatment EUS-guided measurements will be paired with transjugular hepatic venous pressure gradient HVPG measurement as well as non-invasive tests for assessment of portal hypertension
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None